STOCK TITAN

Advansix SEC Filings

ASIX NYSE

Welcome to our dedicated page for Advansix SEC filings (Ticker: ASIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

AdvanSix Inc. filings document an integrated chemistry issuer with common stock traded on the NYSE under ASIX. Its 8-K reports furnish operating results for Nylon Solutions, Plant Nutrients and Chemical Intermediates, cash dividends on common stock, executive and director appointments, committee assignments, and amendments to its senior secured revolving credit facility.

Proxy materials disclose board composition, independence, committee structure, executive compensation, equity awards and shareholder voting matters. The filing record also covers capital structure, financial obligations and governance practices tied to AdvanSix's vertically integrated manufacturing assets, raw-material exposure, plant operations and end markets for nylon, fertilizers and chemical intermediates.

Rhea-AI Summary

AdvanSix Inc. (ASIX) director Donald P. Newman reported a transaction dated 09/30/2025 allocating 1,418 deferred stock units to his deferred stock unit fund under the AdvanSix Deferred Compensation Plan at an indicated value of $19.38 per unit. Each deferred stock unit represents the economic equivalent of one share and will be paid out in shares upon distribution. After this allocation, Mr. Newman beneficially owns 13,497 shares/units, which includes an additional 53 shares credited as dividend equivalents tied to unvested restricted stock units and deferred stock units acquired in transactions exempt from Rule 16a-11. The Form 4 was signed on behalf of Mr. Newman on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) Form 3 filing: Daryl Roberts, identified as a Director, filed an initial Section 16 statement reporting zero shares of AdvanSix common stock beneficially owned. The event date triggering the filing is 09/02/2025 and the filing was signed on 09/08/2025 by Achilles B. Kintiroglou on behalf of the reporting person. No derivative holdings or indirect ownership are disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AdvanSix Inc. (ASIX) Form 3 reports that Dana C. O'Brien, listed at the provided address, is a director of the issuer and filed an initial Section 16 statement. The filing shows zero shares of common stock beneficially owned, and the form is signed on behalf of the reporting person. This is a routine initial ownership disclosure with no recorded beneficial ownership reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AdvanSix Inc. (ASIX) insider sale reported on Form 4. Achilles B. Kintiroglou, SVP and General Counsel, sold 571 shares of AdvanSix common stock on 09/02/2025 at $21.20 per share. After the sale, the reporting person beneficially owned 30,842 shares. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on 11/12/2024, and the Form 4 was signed on 09/03/2025. The disclosure shows a routine, pre-arranged disposition by an officer with a clear compliance disclosure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Notice of proposed sale under Rule 144: This Form 144 indicates that Achilles Kintiroglou intends to sell 571 shares of AdvanSix Inc. common stock through Merrill Lynch (NYC) with an aggregate market value of $12,105.20, with an approximate sale date of 09/02/2025. The shares were acquired on 02/28/2025 through the vesting of a restricted stock unit award granted under the issuer's equity compensation plan. The filing also reports three prior sales in the past three months of 571 shares each on 06/02/2025, 07/02/2025, and 08/01/2025, with gross proceeds of $13,504.15, $14,189.35, and $11,522.78 respectively. The filer attests not to possess undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
other
-
Rhea-AI Summary

AdvanSix Inc. appointed Dana O’Brien and Daryl Roberts to its Board of Directors effective September 2, 2025, increasing the Board to nine members with eight qualifying as independent under NYSE standards. Ms. O’Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee, and Mr. Roberts will serve on the Health, Safety and Environmental Committee and the Compensation and Leadership Development Committee.

Ms. O’Brien most recently served as Senior Vice President and Chief Legal Officer of Olin Corporation and held senior legal roles at several public companies. Mr. Roberts is Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc. There are no related-person transactions or family relationships disclosed, and both will receive standard non-employee director compensation described in the company proxy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
quarterly report
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
current report

FAQ

How many Advansix (ASIX) SEC filings are available on StockTitan?

StockTitan tracks 63 SEC filings for Advansix (ASIX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Advansix (ASIX)?

The most recent SEC filing for Advansix (ASIX) was filed on October 1, 2025.